Sep 08, 2022 / 02:25PM GMT
Larry Biegelsen - Wells Fargo - Analyst
All right. Good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. It is my pleasure to host this session with Axonics. With us, we have Ray Cohen, the CEO; and Dan Dearen, the President and CFO.
In terms of format, it's going to be a fireside chat. If anybody has a question, raise your hand and we will call on you. So Ray and Dan, thanks so much for being here.
Ray Cohen - Axonics, Inc. - CEO
Thank you. Appreciate the invite.
Questions and Answers:
Larry Biegelsen - Wells Fargo - AnalystSo Ray, let's start with the macro environment. On the Q2 call, you indicated that COVID deferrals and procedures slowed down and slowdowns and staffing shortages did not really impact your Q2 results. But you did note some supply chain challenges and higher costs for certain components, which you've been able to manage the impact of so far. So how do you see the macro environment right now? What's getting better, what's getting worse?